SANDRA VALENCIA: Open Payments
NPI 1053357780 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,371 in 36 payments from 15 companies in 2025. Trend: 2023 $953 · 2024 $1,240 · 2025 $1,371
Food & beverage: $1,371
| Company | Payments | Amount |
|---|---|---|
| Kestra Medical Technology Services, Inc. | 4 | $298 |
| Cleerly, Inc. | 1 | $171 |
| Alnylam Pharmaceuticals Inc. | 2 | $149 |
| BridgeBio Pharma, Inc. | 6 | $137 |
| Medtronic, Inc. | 1 | $101 |
| PFIZER INC. | 4 | $92 |
| AstraZeneca Pharmaceuticals LP | 3 | $74 |
| Abbott Laboratories | 3 | $70 |
| Merck Sharp & Dohme LLC | 2 | $57 |
| Boston Scientific Corporation | 2 | $53 |
Products named: Assure WCD, Cleerly Ischemia, Attruby, AMVUTTRA, COREVALVE EVOLUT R, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, VYNDAQEL, WINREVAIR.
Industry payments across FL — which companies pay providers there.
